Pistoia Alliance's 2022 Collaborate to Innovate Conference

When

JavaScript Disabled
JavaScript Disabled
Download ICS Google Calendar iCalendar Office 365 Outlook Live
(Date and time are shown in your browser's local time zone)

Where

Hilton Boston Back Bay
40 Dalton Street, Boston, MA, 02115, Northeast

Event Type

Map Unavailable

What: Pistoia Alliance’s Collaborate to Innovate Conference

Where: Hilton Boston Back Bay

When: November 1-2, 2022

 

Registration for the conference is now closed. Please contact marketing@pistoiaalliance.org for further enquiries.

 

Event Summary

Registration is open for the Pistoia Alliance Annual Fall Conference. Collaborate to Innovate is the driving theme of this in-person member event. Join us for a series of plenary presentations, panel discussions, breakout groups, poster presentations, and networking activities as we examine the challenges and opportunities for pre-competitive collaboration across the biopharma value chain. The main conference will be preceded by a day dedicated to reviewing the status of current and proposed Pistoia Alliance projects that aim to lower barriers to innovation in life science R&D.

 

Project Day, 9am – 6pm, November 1, 2022
The main conference will be preceded by a day dedicated to showcasing and reviewing current and proposed Pistoia Alliance projects that aim to lower barriers to innovation in life science R&D.

 

Conference Day, 9am – 7:30pm, November 2, 2022
Join us for a series of plenary presentations, panel discussions, breakout groups, poster presentations, and networking activities as we examine the challenges and opportunities for pre-competitive collaboration across the biopharma value chain.

 

3 Reasons to Attend

  • Gain new insights on topical issues from top pharma senior R&D leaders
  • Engage in our collaborative projects and help solve shared industry challenges
  • Build your industry network at our dedicated evening networking reception

 

Hotel Information

A special room rate of $249 + tax has been negotiated for Pistoia Alliance conference delegates staying at the Hilton Boston Back Bay Hotel. To book a room at this rate use this link.

Agenda – Project Day – 1 November 2022

PDF Download – Full Agenda

All timings are EST

 

TIME SESSION
ALL DAY Maverick Room
08:30 Introduction & Announcements

  • Becky Upton, President, Pistoia Alliance
08:45 DataFAIRy – Biological Assay Metadata FAIR Annotation
09:15 GMLP – Emergent Good Machine Learning Practices Community
09:30 The IDMP Ontology Project
10:15 Morning Coffee
10:45 Controlled Substance Compliance & Shipping Expert Community

  • Influencing new controlled substance decisions impacting research activities
  • Tools to help stay current with scheduling decisions in major jurisdictions
  • Best practices sharing and Benchmarking
    • Managing controlled substance activities in research environment and shipments
    • Updates from industry experts, consultants/government on trending topics
    • Best practices in shipping across the biopharmaceutical industry
  • Tariff Codes – updates and changes to nomenclature
  • Impact of Brexit and other global trade challenges
  • Jack De Cicco, GSK
  • Jessie bin Song, Merck
  • Birthe Nielsen, Pistoia Alliance
  • Akos Papp, Project Manager, ChemAxon
  • Joe Bradley, CEO, Scitegrity
11:30 The IDMP Ontology Workshop

  • Workshop with IDMP project members and guests
  • Evaluate the Minimal Viable Product delivery of the IDMP project now available for implementation in your company
  • Watch the live demos saving the competency questions of the Clinical Use case
  • Discuss your expectations for the next project phases
  • Gerhard Noelken, Pistoia Alliance
  • Heiner Oberkampf, ACCURIDS
12.15 Lunch
13:15 In Vitro Pharmacology Project

  • High level outline of the IVP
  • Discussion of the secondary pharmacology analyses performed, including challenges and opportunities
  • Solutions proposed specifically for secondary pharmacology (standardised nomenclature and data format)
  • How the Public Private Partnership will address these solutions
  • Future work: ontology for assay information and widening the use of the template to other types of in vitro pharmacology assays
  • Rebecca Racz, Pharmacologist, FDA
  • Larry Callahan, Chemist, FDA
  • Veronique Francois-Newton, Pistoia Alliance
14:00

 

14:30

 FAIR Implementation

  • Template of phase 3 for the FAIR Implementation project to be announced
  • FAIR4Clin Guide

 

Natural Language Processing (NLP) Use Case Database Project
14.45 Afternoon Coffee
15:15 Summary of Lab of the Future sessions and Pistoia Alliance D&I Program

  1. Webinar series overview presentation – Improving the Efficiency and Effectiveness of R&D

As part of our overall theme of Improving the Efficiency and Effectiveness of R&D, each webinar explores the power of collaboration to solve shared challenges, drive transformation and reduce barriers to innovation in R&D. The session will include an overview of 3 webinars launched in Q2-Q3 2022:

  • Collaborate to Innovate the Lab of the Future
  • Data Science and Standards
  • AI/ML in R&D Automation
  1. D&I in STEM Leadership – program presentation

This program is designed to help senior executives and team leaders develop their leadership capabilities and D&I knowledge. It provides a unique opportunity to connect with other leaders from across the life sciences industry, collaborate on best practices, and develop a personal network that will help strengthen career progression and D&I initiatives within our organization.
16:00 The Methods Hub/Database Project

  • Introduction and overview to newcomers of the Methods Database project
  • An interoperable data standard for HPLC-UV methods
  • Method portability across instruments, CDS and Pharmaceutical companies – demonstrations
16.45 Panel Discussion: Data support structure for emerging technologies in non-small molecule drug discovery
This panel discussion will focus on the identification of unmet needs in data processing, integration, and analysis for emerging technologies similar to those established for small molecule drug discovery. Examples include:

  • protein degradation using PROTAC’s (Proteolysis targeting chimeric)
  • protein expression using mRNA’s, oligonucleotide “antisense” technology, gene therapy utilizing CRISPR and, ADC’s (antibody drug conjugates)
  • cell therapy
  • biologics including antibodies
  • Chair: John Wise, Pistoia Alliance
  • Jim Rinker, Elsevier
  • Chris Waller, VP & Chief Scientist, EPAM Systems; Pistoia Alliance Chairman of the Board of Directors
  • Lars Greiffenberg, Senior Director, R&D Information Research, AbbVie
  • Sara Cortese, Managing Director, Accenture
  • Ramesh Durvasula, VP Research IT, Eli Lilly & Co
17.30 Drinks Reception Sponsored by Astrix

Agenda – Conference Day – 2 November 2022

All timings are EST

 

TIME SESSION
09.00 President’s Introduction

  • Becky Upton, President, Pistoia Alliance
09.05 Keynote Presentation I: Regulatory Policy and Innovation

  • How can regulatory policy drive innovation?
  • How are we supporting the new science?
  • The growing importance of RWD/RWE in drug discovery and development
  • The importance of interoperability of data
09.30 Keynote Presentation II: How can regulatory policy support innovation and pre-competitive collaboration?

  • Vada Perkins, Executive Director, Regulatory Policy & Innovation, Bayer
09:55 Keynote Panel Discussion: Innovation in Support of Sustainability in R&D

  • Ginena Harkins, CSP, Director, Safety Health & Environment at AstraZeneca
  • Tara Gorney, Senior Director of Research Lab Systems, R&D Tech, GSK 
  • Maria Cortez, Senior Manager, Accenture
10.40 Morning Break

  • Poster viewing
  • Exhibits
11.10 Partners in R&D Innovation Showcase

Elsevier

Collaborative Drug Discovery

Transformative Scaling the Force multiplier for Scientific Impact

David Lynch, CBO, Strateos
11.55 Keynote Presentation III: The power of collaboration – a cross-industry perspective

  • Ashish Kulkarni, EVP, Chief Innovation Officer, GAF, Board Member, Kebotics
12.25 Lunch

  • Poster viewing
  • Birds of a feather roundtables
  • Exhibits
13.25 The emerging landscape of RNA therapeutics

  • Gilles Georges, VP and Chief Scientific Officer, CAS
13.40 Meet the New Pistoia Alliance Member
14.00 Breakout Sessions

  1. Emerging Science & AI Technologies
    14:00 Table to Text: Natural Language Generation Michael Wu, Sr Informatics Analyst, Genentech (remote), Jingqing Zhang, Head of AI, Pangaea Data Vibhor Gupta, Director, Pangaea Data
    14:15 Machine Learning approaches to data discovery and curation, John Overington, VP, Discovery Informatics, Exscientia
    14.30 Emergent technologies in pharmaceutical enterprise for better ROI, Bikalpa Neupane, Director of Advanced Technology, Takeda
    14:45 Applying Augmented Intelligence to ensure Data Quality, Mya Steadman, Bioinformatics Scientist,Elucidata

    15:00 Identifying Experts with Domain-Specific Knowledge Graphs Mike Iarrobino, Director of Product Management, Copyright Clearance Center 15:15 Q&A Panel Discussion 
    What is the R&D Informatics needs of a modern biopharma organisation?
    What technology can support these needs? What can AI/ML deliver beyond the hype? Pillhun Son, Consultant, CAS Custom Services, Vibhor Gupta, Director, Pangaea Data – John Overington, VP, Discovery Informatics, Exscientia, Mya Steadman, Bioinformatics Scientist, Elucidata, Mike Iarrobino, Director of Product Management, Copyright Clearance Center, Bikalpa Neupane, Director of Advanced Technology, Takeda
    15.45 Close
  2. Data Standards
    Gerhard Noelken,     Pistoia Alliance
    Anca Ciobanu, Pistoia Alliance Data standards
    Explore our standards mapping pilot project
    Discuss the requirements of standards today
    Discuss the gaps and requirements for future standards mapping

  3. The skills gap in STEM
    Lars Greiffenberg,     Senior Director, R&D Information Research, AbbVie
    Becky Upton, President, Pistoia Alliance
    There is a skills gap that is widening in the STEM sector come along to hear how AbbVie are tackling this and to workshop with others on their approach
15.30 Coffee
16.00 Partners in R&D Innovation Showcase

  • Tim Tocci, Associate Director, Innovation Consulting,  EPAM Continuum
16.15 BMS Enabled Findable, Access, Interoperable, Reusable (BE-FAIR) Data to Drive AI and ML Use Cases in Research and Early Development (R&ED)

  • Christopher Willis, Lead IT Business Partner, Precision Medicine, Bristol Myers Squibb
16.30 RWD/RWE Introduction

  • Ramesh Durvasula, VP Research IT, Eli Lilly & Co.
16.35 Keynote Address IV: The Application of Real-World Evidence in Biopharma

  • Context setting with respect to healthcare spending, environmental trends, Real World Evidence (RWE)
  • Innovation with RWE across the value chain including discovery, research, development, and commercialization (with use case examples):
  • RWE in Clinical Trial Design
  • RWE in Regulatory Decision Making
  • Health Equity
  • RWE partnerships and the future of healthcare delivery in the US
  • Christian Nguyen, SVP, Value Evidence Outcomes, Eli Lilly & Co.
17.00 Panel Discussion: Application of RWD in Drug Discovery & Development

  • Matthias Leddin, Principal Data Scientist, Roche
  • Keele Wurst, Senior Director, Epidemiology, GSK
  • Christian Nguyen, SVP, Value Evidence Outcomes, Eli Lilly & Co.
17.30 Closing Remarks, Poster Prizes
17.35 Closing Reception

 

Speakers

 

Event Sponsors



Evening Drinks Reception Sponsor

Sponsorship Opportunities

Our sponsor packages offer service companies the perfect opportunity to engage with senior-level R&D leaders from leading life science institutions. If you have a service offering for this community or want to demonstrate your thought leadership, please email Zahid Tharia about our sponsorship opportunities.

Last Updated on November 2, 2022 by
Categories: Pistoia Alliance